Vitiligo

While there is currently no cure for vitiligo, several interventions aim to halt progression and restore pigment. Treatment selection depends on factors such as disease extent, location of lesions, and patient goals.

Standard therapies include:

• Topical corticosteroids – reduce inflammation and may stimulate repigmentation.
• Calcineurin inhibitors – non‑steroidal options for sensitive areas.
• Phototherapy – narrowband UVB or excimer laser exposure to promote melanocyte activity.
• Depigmentation – for extensive cases, agents like monobenzone lighten remaining pigmented skin for uniform appearance.

Advanced and emerging modalities offered at Liv Hospital:

1. Excimer laser therapy – targeted UVB treatment with high precision.
2. Platelet‑rich plasma (PRP) injections – autologous growth factors that may support melanocyte regeneration.
3. JAK inhibitors – oral or topical medications that modulate immune pathways involved in melanocyte loss.
4. Stem cell therapy – experimental approaches exploring melanocyte transplantation.

Each option carries specific benefits and considerations. A multidisciplinary team, including dermatologists, immunologists, and psychologists, collaborates to create a personalized plan that balances efficacy, safety, and quality of life.